Alumis (ALMS) financial statements

Healthcare · Biotechnology · Market cap $840M

Alumis reported revenue of $24M in fiscal 2025.

Net income was -$243M.

Free cash flow was -$370M, and the company returned $17,000 in net buybacks.

The diluted share count rose 3855% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.4-0.3-0.2-0.100.1202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Alumis's 10-K filings with the SEC.

Fiscal year202320242025
Revenue——$24M
Research and development$138M$266M$386M
Selling, general and admin$20M$35M$92M
Operating income-$158M-$301M-$454M
Pre-tax income—-$294M-$252M
Income tax$0$0-$9M
Net income-$155M-$294M-$243M
EPS (diluted)-$72.08-$10.38-$2.86
Diluted shares2M28M85M
Operating margin——-1886.9%
Net margin——-1011.7%

Balance sheet

Fiscal years, from Alumis's 10-K filings with the SEC.

Fiscal year202320242025
Cash and short-term investments$49M$288M$308M
Total current assets$53M$306M$318M
Property, plant and equipment$22M$21M$18M
Total assets$90M$341M$412M
Total current liabilities$21M$51M$73M
Total liabilities$54M$81M$111M
Shareholders' equity-$339M$260M$301M
Net debt-$46M-$170M-$90M

Cash flow

Fiscal years, from Alumis's 10-K filings with the SEC.

Fiscal year202320242025
Operating cash flow-$130M-$255M-$370M
Capital spending$4M$2M$653,000
Free cash flow-$134M-$257M-$370M
Stock-based compensation$9M$19M$44M
Share buybacks (net)-$64,000-$6,000-$17,000
Free cash flow margin——-1539.2%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ALMS.
Open ALMS in Investingly

Questions

What was Alumis's revenue in 2025?

$24M in fiscal 2025, from its 10-K filing.

How much free cash flow does Alumis generate?

-$370M in fiscal 2025 (operating cash flow minus capital spending).

From Alumis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.